Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Inactivated Vaccines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
CSL Limited
Emergent BioSolutions, Inc
India Pvt Ltd (India)
Sanofi Pasteur
Merck & Co
GlaxoSmithKline
MedImmune, LLC
Johnson & Johnson
Serum Institute
By Type:
DTP
Hepatitis
Pneumococcal
HPV
Polio
Rotavirus
Influenza
MMR
By Application:
Adult
Pediatric
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Inactivated Vaccines Market Overview 2018-2029
-
1.1 China Inactivated Vaccines Industry Development Overview
-
1.2 China Inactivated Vaccines Industry Development History
-
1.3 China Inactivated Vaccines Industry Market Size (2018-2029)
-
1.4 China Inactivated Vaccines Market Analysis by Type from Production Side
-
1.4.1 China Inactivated Vaccines Production Volume, Production Value and Growth Rate of DTP (2018-2029)
-
1.4.2 China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Hepatitis (2018-2029)
-
1.4.3 China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Pneumococcal (2018-2029)
-
1.4.4 China Inactivated Vaccines Production Volume, Production Value and Growth Rate of HPV (2018-2029)
-
1.4.5 China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Polio (2018-2029)
-
1.4.6 China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Rotavirus (2018-2029)
-
1.4.7 China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Influenza (2018-2029)
-
1.4.8 China Inactivated Vaccines Production Volume, Production Value and Growth Rate of MMR (2018-2029)
-
1.5 China Inactivated Vaccines Market Analysis by Application from Consumption End
-
1.5.1 China Inactivated Vaccines Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)
-
1.5.2 China Inactivated Vaccines Sales Volume, Sales Value and Growth Rate of Pediatric (2018-2029)
-
1.6 China Inactivated Vaccines Market Analysis by Region
-
1.6.1 North China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
Chapter 2 China Inactivated Vaccines Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Inactivated Vaccines Market Status and Competition at home and abroad in 2023
-
2.2.2 China Inactivated Vaccines Market Status and Competition Analysis in 2023
-
2.2.3 China Inactivated Vaccines Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Inactivated Vaccines Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Inactivated Vaccines Industry Development
Chapter 3 Inactivated VaccinesIndustry Chain Analysis
-
3.1 Inactivated Vaccines Industry Chain
-
3.2 Inactivated Vaccines Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Inactivated Vaccines Market
-
3.3 Inactivated Vaccines Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Inactivated Vaccines Market
Chapter 4 China Inactivated Vaccines Market, by Type
-
4.1 China Inactivated Vaccines Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Inactivated Vaccines Total Production Volume and Growth Rate from Production Side
-
4.5 China Inactivated Vaccines Production Volume and Growth Rate, by Type
-
4.5.1 China Inactivated Vaccines Production Volume and Growth Rate of DTP
-
4.5.2 China Inactivated Vaccines Production Volume and Growth Rate of Hepatitis
-
4.5.3 China Inactivated Vaccines Production Volume and Growth Rate of Pneumococcal
-
4.5.4 China Inactivated Vaccines Production Volume and Growth Rate of HPV
-
4.5.5 China Inactivated Vaccines Production Volume and Growth Rate of Polio
-
4.5.6 China Inactivated Vaccines Production Volume and Growth Rate of Rotavirus
-
4.5.7 China Inactivated Vaccines Production Volume and Growth Rate of Influenza
-
4.5.8 China Inactivated Vaccines Production Volume and Growth Rate of MMR
Chapter 5 China Inactivated Vaccines Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Inactivated Vaccines Total Market Size and Growth Rate from Consumption End
-
5.5 China Inactivated Vaccines Market Size and Growth Rate, by Application
-
5.5.1 China Inactivated Vaccines Market Size and Growth Rate of Adult
-
5.5.2 China Inactivated Vaccines Market Size and Growth Rate of Pediatric
Chapter 6 China Inactivated Vaccines Market, by Region
-
6.1 China Inactivated Vaccines Production Volume and Production Value, by Region
-
6.2 China Inactivated Vaccines Sales Volume and Sales Value, by Region
Chapter 7 North China Inactivated Vaccines Market Analysis
-
7.1 North China Inactivated Vaccines Market, by Type
-
7.2 North China Inactivated Vaccines Market, by Application
Chapter 8 Central China Inactivated Vaccines Market Analysis
-
8.1 Central China Inactivated Vaccines Market, by Type
-
8.2 Central China Inactivated Vaccines Market, by Application
Chapter 9 South China Inactivated Vaccines Market Analysis
-
9.1 South China Inactivated Vaccines Market, by Type
-
9.2 South China Inactivated Vaccines Market, by Application
Chapter 10 East China Inactivated Vaccines Market Analysis
-
10.1 East China Inactivated Vaccines Market, by Type
-
10.2 East China Inactivated Vaccines Market, by Application
Chapter 11 Northeast China Inactivated Vaccines Market Analysis
-
11.1 Northeast China Inactivated Vaccines Market, by Type
-
11.2 Northeast China Inactivated Vaccines Market, by Application
Chapter 12 Southwest China Inactivated Vaccines Market Analysis
-
12.1 Southwest China Inactivated Vaccines Market, by Type
-
12.2 Southwest China Inactivated Vaccines Market, by Application
Chapter 13 Northwest China Inactivated Vaccines Market Analysis
-
13.1 Northwest China Inactivated Vaccines Market, by Type
-
13.2 Northwest China Inactivated Vaccines Market, by Application
Chapter 14 Company Profiles
-
14.1 CSL Limited
-
14.1.1 CSL Limited Company Profile
-
14.1.2 CSL Limited Inactivated Vaccines Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Emergent BioSolutions, Inc
-
14.2.1 Emergent BioSolutions, Inc Company Profile
-
14.2.2 Emergent BioSolutions, Inc Inactivated Vaccines Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 India Pvt Ltd (India)
-
14.3.1 India Pvt Ltd (India) Company Profile
-
14.3.2 India Pvt Ltd (India) Inactivated Vaccines Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Sanofi Pasteur
-
14.4.1 Sanofi Pasteur Company Profile
-
14.4.2 Sanofi Pasteur Inactivated Vaccines Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Merck & Co
-
14.5.1 Merck & Co Company Profile
-
14.5.2 Merck & Co Inactivated Vaccines Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 GlaxoSmithKline
-
14.6.1 GlaxoSmithKline Company Profile
-
14.6.2 GlaxoSmithKline Inactivated Vaccines Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 MedImmune, LLC
-
14.7.1 MedImmune, LLC Company Profile
-
14.7.2 MedImmune, LLC Inactivated Vaccines Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Johnson & Johnson
-
14.8.1 Johnson & Johnson Company Profile
-
14.8.2 Johnson & Johnson Inactivated Vaccines Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Serum Institute
-
14.9.1 Serum Institute Company Profile
-
14.9.2 Serum Institute Inactivated Vaccines Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Inactivated Vaccines Industry Research Conclusions
-
15.2 Inactivated Vaccines Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Inactivated Vaccines Industry Market Size (2018-2029)
-
Figure China Inactivated Vaccines Production Volume, Production Value and Growth Rate of DTP (2018-2029)
-
Figure China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Hepatitis (2018-2029)
-
Figure China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Pneumococcal (2018-2029)
-
Figure China Inactivated Vaccines Production Volume, Production Value and Growth Rate of HPV (2018-2029)
-
Figure China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Polio (2018-2029)
-
Figure China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Rotavirus (2018-2029)
-
Figure China Inactivated Vaccines Production Volume, Production Value and Growth Rate of Influenza (2018-2029)
-
Figure China Inactivated Vaccines Production Volume, Production Value and Growth Rate of MMR (2018-2029)
-
Figure China Inactivated Vaccines Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)
-
Figure China Inactivated Vaccines Sales Volume, Sales Value and Growth Rate of Pediatric (2018-2029)
-
Figure North China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Central China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
Figure South China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
Figure East China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Inactivated Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Inactivated Vaccines Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Inactivated Vaccines Market Share by Type in 2018
-
Figure China Inactivated Vaccines Market Share by Type in 2023
-
Figure China Inactivated Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Inactivated Vaccines Production Volume and Growth Rate of DTP (2018-2023)
-
Figure China Inactivated Vaccines Production Volume and Growth Rate of Hepatitis (2018-2023)
-
Figure China Inactivated Vaccines Production Volume and Growth Rate of Pneumococcal (2018-2023)
-
Figure China Inactivated Vaccines Production Volume and Growth Rate of HPV (2018-2023)
-
Figure China Inactivated Vaccines Production Volume and Growth Rate of Polio (2018-2023)
-
Figure China Inactivated Vaccines Production Volume and Growth Rate of Rotavirus (2018-2023)
-
Figure China Inactivated Vaccines Production Volume and Growth Rate of Influenza (2018-2023)
-
Figure China Inactivated Vaccines Production Volume and Growth Rate of MMR (2018-2023)
-
Figure China Inactivated Vaccines Market Share by Application in 2018
-
Figure China Inactivated Vaccines Market Share by Application in 2023
-
Figure China Inactivated Vaccines Total Market Size and Growth Rate from Consumption End
-
Figure China Inactivated Vaccines Market Size and Growth Rate of Adult (2018-2023)
-
Figure China Inactivated Vaccines Market Size and Growth Rate of Pediatric (2018-2023)
-
Table China Inactivated Vaccines Production Volume by Region (2018-2023)
-
Table China Inactivated Vaccines Production Volume Share by Region (2018-2023)
-
Figure China Inactivated Vaccines Production Volume Share by Region (2018-2023)
-
Table China Inactivated Vaccines Production Value by Region (2018-2023)
-
Table China Inactivated Vaccines Production Value Share by Region (2018-2023)
-
Figure China Inactivated Vaccines Production Value Share by Region (2018-2023)
-
Table China Inactivated Vaccines Sales Volume by Region (2018-2023)
-
Table China Inactivated Vaccines Sales Volume Share by Region (2018-2023)
-
Figure China Inactivated Vaccines Sales Volume Share by Region (2018-2023)
-
Table China Inactivated Vaccines Sales Value by Region (2018-2023)
-
Table China Inactivated Vaccines Sales Value Share by Region (2018-2023)
-
Figure China Inactivated Vaccines Sales Value Share by Region (2018-2023)
-
Table North China Inactivated Vaccines Production Volume by Type (2018-2023)
-
Table North China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Figure North China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Table North China Inactivated Vaccines Sales Volume by Application (2018-2023)
-
Table North China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Figure North China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Table Central China Inactivated Vaccines Production Volume by Type (2018-2023)
-
Table Central China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Figure Central China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Table Central China Inactivated Vaccines Sales Volume by Application (2018-2023)
-
Table Central China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Central China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Table South China Inactivated Vaccines Production Volume by Type (2018-2023)
-
Table South China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Figure South China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Table South China Inactivated Vaccines Sales Volume by Application (2018-2023)
-
Table South China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Figure South China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Table East China Inactivated Vaccines Production Volume by Type (2018-2023)
-
Table East China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Figure East China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Table East China Inactivated Vaccines Sales Volume by Application (2018-2023)
-
Table East China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Figure East China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Table Northeast China Inactivated Vaccines Production Volume by Type (2018-2023)
-
Table Northeast China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Figure Northeast China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Table Northeast China Inactivated Vaccines Sales Volume by Application (2018-2023)
-
Table Northeast China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Table Southwest China Inactivated Vaccines Production Volume by Type (2018-2023)
-
Table Southwest China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Figure Southwest China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Table Southwest China Inactivated Vaccines Sales Volume by Application (2018-2023)
-
Table Southwest China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Table Northwest China Inactivated Vaccines Production Volume by Type (2018-2023)
-
Table Northwest China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Figure Northwest China Inactivated Vaccines Production Volume Share by Type (2018-2023)
-
Table Northwest China Inactivated Vaccines Sales Volume by Application (2018-2023)
-
Table Northwest China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Inactivated Vaccines Sales Volume Share by Application (2018-2023)
-
Table CSL Limited Company Profile
-
Table CSL Limited Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
Table Emergent BioSolutions, Inc Company Profile
-
Table Emergent BioSolutions, Inc Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
Table India Pvt Ltd (India) Company Profile
-
Table India Pvt Ltd (India) Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
Table Sanofi Pasteur Company Profile
-
Table Sanofi Pasteur Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
Table Merck & Co Company Profile
-
Table Merck & Co Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
Table MedImmune, LLC Company Profile
-
Table MedImmune, LLC Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
Table Serum Institute Company Profile
-
Table Serum Institute Inactivated Vaccines Revenue, Price and Gross (2018-2023)
-
